Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1324

1.

Regional High Iron in the Substantia Nigra Differentiates Parkinson's Disease Patients From Healthy Controls.

Ghassaban K, He N, Sethi SK, Huang P, Chen S, Yan F, Haacke EM.

Front Aging Neurosci. 2019 May 27;11:106. doi: 10.3389/fnagi.2019.00106. eCollection 2019.

PMID:
31191294
2.

Modulation of azole sensitivity and filamentation by GPI15, encoding a subunit of the first GPI biosynthetic enzyme, in Candida albicans.

Jain P, Garai P, Sethi SC, Naqvi N, Yadav B, Kumar P, Singh SL, Yadav U, Bhatnagar S, Rahul, Puri N, Muthuswami R, Komath SS.

Sci Rep. 2019 Jun 11;9(1):8508. doi: 10.1038/s41598-019-44919-4.

3.

Comparison of Haemodynamic Response to Inhalational Bolus with Desflurane in Normotensive and Hypertensive Patients Undergoing Laparoscopic Cholecystectomy.

Kumari K, Samra T, Saini V, Sethi S, Banerjee N, Sharma S.

Turk J Anaesthesiol Reanim. 2019 Jun;47(3):165-172. doi: 10.5152/TJAR.2018.93457. Epub 2018 May 2.

4.

Comparison of air Q® insertion techniques in pediatric patients with fiberoptic bronchoscopic assessment.

Gaddam M, Sethi S, Jain A, Saini V.

Korean J Anesthesiol. 2019 Jun 4. doi: 10.4097/kja.d.18.00367. [Epub ahead of print]

5.

Intravascular cardiac lipoproteinosis: extrarenal manifestation of lipoprotein glomerulopathy.

Morris CS, Bois MC, Aust CH, Thomas R, Sethi S, Maleszewski JJ.

Cardiovasc Pathol. 2019 May 7;42:6-9. doi: 10.1016/j.carpath.2019.04.006. [Epub ahead of print]

PMID:
31158730
6.

Cardiovascular safety of revefenacin, a once-daily, lung-selective, long-acting muscarinic antagonist for nebulized therapy of chronic obstructive pulmonary disease: Evaluation in phase 3 clinical trials.

Donohue JF, Feldman G, Sethi S, Barnes CN, Pendyala S, Bourdet D, Crater G.

Pulm Pharmacol Ther. 2019 May 29:101808. doi: 10.1016/j.pupt.2019.101808. [Epub ahead of print]

7.

Revefenacin, a once-daily, lung-selective, long-acting muscarinic antagonist for nebulized therapy: Safety and tolerability results of a 52-week phase 3 trial in moderate to very severe chronic obstructive pulmonary disease.

Donohue JF, Kerwin E, Sethi S, Haumann B, Pendyala S, Dean L, Barnes CN, Moran EJ, Crater G.

Respir Med. 2019 May 23;153:38-43. doi: 10.1016/j.rmed.2019.05.010. [Epub ahead of print]

PMID:
31150963
8.

Elucidation of drug resistant mutations of Mycobacterium tuberculosis by whole genome sequencing from North India.

Sethi S, Hao Y, Brown SM, Walker T, Yadav R, Zaman K, Aggarwal AN, Behera D.

J Glob Antimicrob Resist. 2019 May 20. pii: S2213-7165(19)30129-8. doi: 10.1016/j.jgar.2019.05.019. [Epub ahead of print]

PMID:
31121336
9.

Cerebral microbleed detection using Susceptibility Weighted Imaging and deep learning.

Liu S, Utriainen D, Chai C, Chen Y, Wang L, Sethi SK, Xia S, Haacke EM.

Neuroimage. 2019 May 20;198:271-282. doi: 10.1016/j.neuroimage.2019.05.046. [Epub ahead of print]

PMID:
31121296
10.

Clinical procedural skills assessment during internship in ophthalmology.

Sethi S, Badyal DK.

J Adv Med Educ Prof. 2019 Apr;7(2):56-61.

11.

Exostosin 1/Exostosin 2-Associated Membranous Nephropathy.

Sethi S, Madden BJ, Debiec H, Charlesworth MC, Gross L, Ravindran A, Hummel AM, Specks U, Fervenza FC, Ronco P.

J Am Soc Nephrol. 2019 Jun;30(6):1123-1136. doi: 10.1681/ASN.2018080852. Epub 2019 May 6.

PMID:
31061139
12.

Transverse Sinus Thrombosis in Neurobrucellosis: A Rare Complication.

Chaudhary H, Seetharaman K, Kasinathan A, Saini AG, Kumar R, Gautam V, Sethi S, Singh P.

Neurologist. 2019 May;24(3):109-110. doi: 10.1097/NRL.0000000000000232. No abstract available.

PMID:
31045721
13.

Peritubal Infiltration of Fentanyl Compared to Dexmedetomidine with Ropivacaine in Percutaneous Nephrolithotomy: A Randomized Comparative Analysis.

Soni S, Parmar K, Charan SM, Sethi S, Naik NB.

Anesth Essays Res. 2019 Jan-Mar;13(1):1-6. doi: 10.4103/aer.AER_1_19.

14.

Letter to editor regarding "comparison of efficacy of haloperidol and olanzapine in the treatment of delirium".

Kumar P, Khurana H, Kumar A, Sethi S.

Indian J Psychiatry. 2019 Mar-Apr;61(2):218-219. doi: 10.4103/psychiatry.IndianJPsychiatry_85_18. No abstract available.

15.

Hemolytic uremic syndrome in a developing country: Consensus guidelines.

Bagga A, Khandelwal P, Mishra K, Thergaonkar R, Vasudevan A, Sharma J, Patnaik SK, Sinha A, Sethi S, Hari P, Dragon-Durey MA; Indian Society of Pediatric Nephrology.

Pediatr Nephrol. 2019 Apr 15. doi: 10.1007/s00467-019-04233-7. [Epub ahead of print]

PMID:
30989342
16.

Endoscopic management of postcholecystectomy biliary leak: when and how? A nationwide study.

Abbas A, Sethi S, Brady P, Taunk P.

Gastrointest Endosc. 2019 Apr 12. pii: S0016-5107(19)31589-5. doi: 10.1016/j.gie.2019.03.1173. [Epub ahead of print]

PMID:
30986401
17.

Open-Label Clinical Trials of Oral Pulse Dexamethasone for Adults with Idiopathic Nephrotic Syndrome.

Cho ME, Branton MH, Smith DA, Bartlett L, Howard L, Reynolds JC, Rosenstein D, Sethi S, Nava MB, Barisoni L, Fervenza FC, Kopp JB.

Am J Nephrol. 2019;49(5):377-385. doi: 10.1159/000497064. Epub 2019 Apr 9.

PMID:
30965344
18.

AMPLIFY: a randomized, Phase III study evaluating the efficacy and safety of aclidinium/formoterol vs monocomponents and tiotropium in patients with moderate-to-very severe symptomatic COPD.

Sethi S, Kerwin E, Watz H, Ferguson GT, Mroz RM, Segarra R, Molins E, Jarreta D, Garcia Gil E.

Int J Chron Obstruct Pulmon Dis. 2019 Mar 22;14:667-682. doi: 10.2147/COPD.S189138. eCollection 2019.

19.

Allocation of the Highest Quality Kidneys and Transplant Outcomes Under the New Kidney Allocation System.

Sethi S, Najjar R, Peng A, Mirocha J, Vo A, Bunnapradist S, Jordan SC, Huang E.

Am J Kidney Dis. 2019 May;73(5):605-614. doi: 10.1053/j.ajkd.2018.12.036. Epub 2019 Mar 28.

PMID:
30929853
20.

Radiation Training, Radiation Protection, and Fluoroscopy Utilization Practices Among US Therapeutic Endoscopists.

Sethi S, Barakat MT, Friedland S, Banerjee S.

Dig Dis Sci. 2019 Mar 25. doi: 10.1007/s10620-019-05564-z. [Epub ahead of print]

PMID:
30911863
21.

Evaluation of different bioimpedance methods for assessing body composition in Asian non-dialysis chronic kidney disease patients.

Lee SW, Ngoh CLY, Chua HR, Haroon S, Wong WK, Lee EJ, Lau TW, Sethi S, Teo BW.

Kidney Res Clin Pract. 2019 Mar 31;38(1):71-80. doi: 10.23876/j.krcp.18.0069.

22.

Clinical Relevance of PostTransplant Donor Specific Antibodies (DSAs) in Patients Receiving Desensitization for HLA Incompatible Kidney Transplantation.

Vo AA, Aubert O, Haas M, Huang E, Zhang X, Choi J, Peng A, Najjar R, Sethi S, Ammerman N, Lim K, Jordan SC.

Transplantation. 2019 Mar 6. doi: 10.1097/TP.0000000000002691. [Epub ahead of print]

PMID:
30883456
23.

Depression among tuberculosis patients attending a DOTS centre in a rural area of Delhi: A cross-sectional study.

Salodia UP, Sethi S, Khokhar A.

Indian J Public Health. 2019 Jan-Mar;63(1):39-43. doi: 10.4103/ijph.IJPH_109_18.

24.

Evaluation of biomarkers: Galactomannan and 1,3-beta-D-glucan assay for the diagnosis of invasive fungal infections in immunocompromised patients from a tertiary care centre.

Singh S, Kaur H, Choudhary H, Sethi S, Malhotra P, Gupta KL, Rudramurthy SM, Chakrabarti A.

Indian J Med Microbiol. 2018 Oct-Dec;36(4):557-563. doi: 10.4103/ijmm.IJMM_18_366.

PMID:
30880706
25.

Genetic Characterization of Second-Line Drug-Resistant and Extensively Drug-Resistant Mycobacterium tuberculosis from the Northern Region of India.

Yadav R, Saini A, Mankotia J, Khaneja R, Agarwal P, Sethi S.

J Epidemiol Glob Health. 2018 Dec;8(3-4):220-224. doi: 10.2991/j.jegh.2018.02.100.

PMID:
30864767
26.

Effectiveness of oral health education on oral hygiene status among schizophrenic patients: A randomized controlled study.

Agarwal D, Kumar A, B C M, Sethi S, Yadav V, Shyam R, Kumar V.

Spec Care Dentist. 2019 May;39(3):255-261. doi: 10.1111/scd.12373. Epub 2019 Mar 12.

PMID:
30861167
27.

Mice With a Brd4 Mutation Represent a New Model of Nephrocalcinosis.

Gorvin CM, Loh NY, Stechman MJ, Falcone S, Hannan FM, Ahmad BN, Piret SE, Reed AA, Jeyabalan J, Leo P, Marshall M, Sethi S, Bass P, Roberts I, Sanderson J, Wells S, Hough TA, Bentley L, Christie PT, Simon MM, Mallon AM, Schulz H, Cox RD, Brown MA, Huebner N, Brown SD, Thakker RV.

J Bone Miner Res. 2019 Mar 4. doi: 10.1002/jbmr.3695. [Epub ahead of print]

PMID:
30830987
28.

A Single-Center Case Series Describing Tracheobronchial Bonastent Implantation.

Avasarala SK, Sethi S, Machuzak M, Almeida FA, Gildea TR.

J Bronchology Interv Pulmonol. 2019 Mar 1. doi: 10.1097/LBR.0000000000000567. [Epub ahead of print]

PMID:
30829896
29.

Comparative Analyses of the 12 Most Abundant PCB Congeners Detected in Human Maternal Serum for Activity at the Thyroid Hormone Receptor and Ryanodine Receptor.

Sethi S, Morgan RK, Feng W, Lin Y, Li X, Luna C, Koch M, Bansal R, Duffel MW, Puschner B, Zoeller RT, Lehmler HJ, Pessah IN, Lein PJ.

Environ Sci Technol. 2019 Apr 2;53(7):3948-3958. doi: 10.1021/acs.est.9b00535. Epub 2019 Mar 19.

PMID:
30821444
30.

Indirect derivation of biological variation data and analytical performance specifications for therapeutic drug monitoring activities.

Chai JH, Flatman R, Teis B, Sethi SK, Badrick T, Loh TP.

Pathology. 2019 Apr;51(3):281-285. doi: 10.1016/j.pathol.2018.12.418. Epub 2019 Feb 23.

PMID:
30803737
31.

Renal biopsy findings in patients with extreme obesity: more heterogeneous than you think.

Fervenza FC, Sethi S.

Kidney Int. 2019 Mar;95(3):495-498. doi: 10.1016/j.kint.2018.12.008.

PMID:
30784658
33.

The Use of AngioVac Thrombectomy in IVC Filter-Associated IVC Thrombosis.

Saha A, Poterucha TJ, Parikh SA, Kirtane AJ, Sethi SS, Green P.

JACC Cardiovasc Interv. 2019 Mar 11;12(5):e41-e43. doi: 10.1016/j.jcin.2018.10.044. Epub 2019 Feb 13. No abstract available.

PMID:
30772292
34.

Is care really shared? A systematic review of collaborative care (shared care) interventions for adult cancer patients with depression.

Shaw J, Sethi S, Vaccaro L, Beatty L, Kirsten L, Kissane D, Kelly B, Mitchell G, Sherman K, Turner J.

BMC Health Serv Res. 2019 Feb 14;19(1):120. doi: 10.1186/s12913-019-3946-z.

35.

Pediatric intradialytic hypotension: recommendations from the Pediatric Continuous Renal Replacement Therapy (PCRRT) Workgroup.

Raina R, Lam S, Raheja H, Krishnappa V, Hothi D, Davenport A, Chand D, Kapur G, Schaefer F, Sethi SK, McCulloch M, Bagga A, Bunchman T, Warady BA.

Pediatr Nephrol. 2019 May;34(5):925-941. doi: 10.1007/s00467-018-4190-1. Epub 2019 Feb 8.

PMID:
30734850
36.

Early clinical experience using donor-derived cell-free DNA to detect rejection in kidney transplant recipients.

Huang E, Sethi S, Peng A, Najjar R, Mirocha J, Haas M, Vo A, Jordan SC.

Am J Transplant. 2019 Jun;19(6):1663-1670. doi: 10.1111/ajt.15289. Epub 2019 Mar 29.

PMID:
30725531
37.

Glaucoma and degenerative vitreoretinopathy in a girl with Nicolaides-Baraitser syndrome.

Sethi S, Thau A, Kaplan P, Asher SB, Levin AV.

J AAPOS. 2019 Jan 29. pii: S1091-8531(19)30012-6. doi: 10.1016/j.jaapos.2018.12.002. [Epub ahead of print]

PMID:
30707941
38.

Ristretto MRE: A generalized multi-shot GRE-MRE sequence.

Guenthner C, Sethi S, Troelstra M, Dokumaci AS, Sinkus R, Kozerke S.

NMR Biomed. 2019 May;32(5):e4049. doi: 10.1002/nbm.4049. Epub 2019 Jan 29.

PMID:
30697827
39.

Actinomycosis which Impersonates Malignancy.

Gelada K, Halli R, Mograwala H, Sethi S.

Ann Maxillofac Surg. 2018 Jul-Dec;8(2):358-360. doi: 10.4103/ams.ams_15_18.

40.

Hymenolepis diminuta infection in a child from urban area of North India: A rare case report.

Sethi S, Gupta S, Jayshree M, Mewara A, Khurana S.

Trop Parasitol. 2018 Jul-Dec;8(2):118-120. doi: 10.4103/tp.TP_31_18. Epub 2018 Dec 27.

41.

Comparative evaluation of enzyme-linked immunosorbent assay with rapid plasma reagin for screening of syphilis in blood donors.

Sachdev S, Sharma AK, Sethi S, Garg S, Lamba DS, Sharma RR, Marwaha N.

Asian J Transfus Sci. 2018 Jul-Dec;12(2):165-168. doi: 10.4103/ajts.AJTS_126_17.

42.

C3 glomerulopathy - understanding a rare complement-driven renal disease.

Smith RJH, Appel GB, Blom AM, Cook HT, D'Agati VD, Fakhouri F, Fremeaux-Bacchi V, Józsi M, Kavanagh D, Lambris JD, Noris M, Pickering MC, Remuzzi G, de Córdoba SR, Sethi S, Van der Vlag J, Zipfel PF, Nester CM.

Nat Rev Nephrol. 2019 Mar;15(3):129-143. doi: 10.1038/s41581-018-0107-2. Review.

PMID:
30692664
43.

Bacterial regulation of macrophage bacterial recognition receptors in COPD are differentially modified by budesonide and fluticasone propionate.

Provost KA, Smith M, Miller-Larsson A, Gudleski GD, Sethi S.

PLoS One. 2019 Jan 24;14(1):e0207675. doi: 10.1371/journal.pone.0207675. eCollection 2019.

44.

Acute exacerbations in chronic obstructive pulmonary disease: should we use antibiotics and if so, which ones?

Jacobs DM, Pandit U, Sethi S.

Curr Opin Infect Dis. 2019 Apr;32(2):143-151. doi: 10.1097/QCO.0000000000000533.

PMID:
30672788
45.

Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies.

Bobart SA, De Vriese AS, Pawar AS, Zand L, Sethi S, Giesen C, Lieske JC, Fervenza FC.

Kidney Int. 2019 Feb;95(2):429-438. doi: 10.1016/j.kint.2018.10.021.

PMID:
30665573
46.

Polychlorinated biphenyls influence on autism spectrum disorder risk in the MARBLES cohort.

Granillo L, Sethi S, Keil KP, Lin Y, Ozonoff S, Iosif AM, Puschner B, Schmidt RJ.

Environ Res. 2019 Apr;171:177-184. doi: 10.1016/j.envres.2018.12.061. Epub 2018 Dec 25.

PMID:
30665119
47.

Achieving the end game: employing "vaccine diplomacy" to eradicate polio in Pakistan.

Shakeel SI, Brown M, Sethi S, Mackey TK.

BMC Public Health. 2019 Jan 17;19(1):79. doi: 10.1186/s12889-019-6393-1.

48.

Long-term safety and efficacy of formoterol fumarate inhalation solution in patients with moderate-to-severe COPD.

Hanania NA, Sethi S, Koltun A, Ward JK, Spanton J, Ng D.

Int J Chron Obstruct Pulmon Dis. 2018 Dec 27;14:117-127. doi: 10.2147/COPD.S173595. eCollection 2019.

49.

A loop-mediated isothermal amplification assay for the diagnosis of pulmonary tuberculosis.

Sharma G, Tewari R, Dhatwalia SK, Yadav R, Behera D, Sethi S.

Lett Appl Microbiol. 2019 Mar;68(3):219-225. doi: 10.1111/lam.13115.

PMID:
30636048
50.

A spray dried Nelfinavir Mesylate particles for enhanced oral bioavailability: Systematic formulation optimization and in-vivo performance.

Kamboj S, Sethi S, Rana V.

Colloids Surf B Biointerfaces. 2019 Apr 1;176:288-299. doi: 10.1016/j.colsurfb.2019.01.006. Epub 2019 Jan 3.

PMID:
30634155

Supplemental Content

Support Center